Plunkett Research Online: IntelliPharmaCeutics International Inc

INTELLIPHARMACEUTICS INTERNATIONAL INC (IPCI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

IntelliPharmaceutics International, Inc. researches, develops and manufactures controlled-release and targeted novel oral solid drugs for use in the treatment of neurological disorders, cardiovascular diseases and gastrointestinal issues as well as pain and infection. The company’s patented Hyperma.....



IntelliPharmaCeutics International Inc
Ticker: IPCI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 416 798-3001
Fax: 416 798-3007
Address: 30 Worcester Road
Toronto, ON M9W 5X2 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Biopharmaceuticals Development
Controlled-Release Technologies
Generic Pharmaceuticals
Novel Oral Solid Drugs
ContactsDescription
Isa OdidiCEO/Chairman of the Board/Director
Domenic Della PennaCFO
See More
IntelliPharmaceutics International, Inc. researches, develops and manufactures controlled-release and targeted novel oral solid drugs for use in the treatment of neurological disorders, cardiovascular diseases and gastrointestinal issues as well as pain and infection. The company’s patented Hyperma.....See More See More

Auditor: MNP LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Hypermatrix
OxyContin
Lyrica
Focalin XR
Effexor SR
Protonix
Seroquel XR
Keppra XR
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: